You are here

Article Text

Article menu
Download PDFPDF
Research Article
Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
  1. D C Mangham,
  2. D C Rowlands,
  3. K M Newbold,
  4. G M Reynolds,
  5. J W Fielding,
  6. M T Hallissey
  1. Department of Pathology, University of Birmingham.

    Abstract

    It has been proposed that immunostaining with PC10, a monoclonal antibody against proliferating cell nuclear antigen (PCNA), is of prognostic value in gastric carcinoma. Gastric carcinomas from a series of 90 patients in whom survival data were known have been studied. There was no relation between the degree of PC10 immunostaining assessed semiquantitatively and survival.

    https://doi.org/10.1136/jcp.47.5.473

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.